Zebrafish as a model to assess cancer heterogeneity, progression and relapse

Jessica S. Blackburn, David M. Langenau

Research output: Contribution to journalReview articlepeer-review

41 Scopus citations

Abstract

Clonal evolution is the process by which genetic and epigenetic diversity is created within malignant tumor cells. This process culminates in a heterogeneous tumor, consisting of multiple subpopulations of cancer cells that often do not contain the same underlying mutations. Continuous selective pressure permits outgrowth of clones that harbor lesions that are capable of enhancing disease progression, including those that contribute to therapy resistance, metastasis and relapse. Clonal evolution and the resulting intratumoral heterogeneity pose a substantial challenge to biomarker identification, personalized cancer therapies and the discovery of underlying driver mutations in cancer. The purpose of this Review is to highlight the unique strengths of zebrafish cancer models in assessing the roles that intratumoral heterogeneity and clonal evolution play in cancer, including transgenesis, imaging technologies, high-throughput cell transplantation approaches and in vivo single-cell functional assays.

Original languageEnglish
Pages (from-to)755-762
Number of pages8
JournalDMM Disease Models and Mechanisms
Volume7
Issue number7
DOIs
StatePublished - Jul 2014

Keywords

  • Cancer stem cell
  • Fluorescence
  • Intratumoral
  • Single cell
  • Targeted therapy
  • Tumor

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Medicine (miscellaneous)
  • Immunology and Microbiology (miscellaneous)
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Zebrafish as a model to assess cancer heterogeneity, progression and relapse'. Together they form a unique fingerprint.

Cite this